Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and rubitecan

phosphatidylcholines has been researched along with rubitecan in 3 studies

Compound Research Comparison

Studies
(phosphatidylcholines)		Trials
(phosphatidylcholines)		Recent Studies (post-2010)
(phosphatidylcholines)		Studies
(rubitecan)		Trials
(rubitecan)		Recent Studies (post-2010) (rubitecan)
32,2044435,5931493422

Protein Interaction Comparison

ProteinTaxonomyphosphatidylcholines (IC50)rubitecan (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)5.1

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilbert, BE; Giovanella, BC; Kleinerman, ES; Knight, V; Koshkina, NV; Waldrep, JC1
Fang, XL; Li, JC; Sha, XY; Zhang, LJ1
Chen, J; Chu, XZ; Guo, JX; Ping, QN; Song, MM1

Other Studies

3 other study(ies) available for phosphatidylcholines and rubitecan

ArticleYear
9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
    Annals of the New York Academy of Sciences, 2000, Volume: 922

    Topics: Aerosols; Animals; Antineoplastic Agents; Bone Neoplasms; Camptothecin; Colonic Neoplasms; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron; Osteosarcoma; Particle Size; Phosphatidylcholines; Xenograft Model Antitumor Assays

2000
[9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:11

    Topics: Animals; Antineoplastic Agents; Camptothecin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Hexoses; Liver; Lung; Macrophages, Peritoneal; Mice; Nanoparticles; Particle Size; Phagocytosis; Phosphatidylcholines; Polyethylene Glycols; Tissue Distribution

2005
Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin.
    Drug development and industrial pharmacy, 2006, Volume: 32, Issue:6

    Topics: Animals; Antineoplastic Agents; Camptothecin; Cholesterol; Drug Compounding; Feasibility Studies; Glycine max; Hydrogenation; Injections, Intravenous; Liposomes; Male; Particle Size; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Solubility

2006